DXCM - DexCom, Inc. Последние новости | Finranks

Видео

19.02.2026

Positive

The Big 3: VZ, DXCM, AMAT

13.01.2026

Neutral

Watch CNBC's exclusive interview with Dexcom CEO Jake Leach

05.08.2025

Positive

Dexcom's Arizona facility can service good portion of U.S. business, says CEO

Повышения / Понижения рейтинга

Тикер	Фирма	Изменение рейтинга	Целевая цена	Дата
DXCM	Evercore ISI	In-line	undefined >> $68	November 25th 2025
DXCM	Stifel	Buy	undefined >> $85	October 21st 2025
DXCM	Oppenheimer	Perform	undefined >> undefined	September 8th 2025
DXCM	Argus	Buy	undefined >> $100	August 21st 2025
DXCM	Truist	Buy	undefined >> $102	June 16th 2025
DXCM	Goldman	Buy	undefined >> $104	May 30th 2025

Пресс-релизы

11.03.2026

Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026

BARCELONA, Spain--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for people with all types of diabetes and share more details about future product features across its global portfolio at the upcoming 19th annual Advanced Technologies and Treatments for Diabetes Conference in Barcelona, March 11-14, 2026. “There is no better global stage than ATTD to showcase how we're.